Grace Niemiro

Dr. Grace Niemiro

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2024 in Cancer Research Communications
Verified
Journal Article
Open access
PDF file
Forrest BakerForrest Baker
Forrest Baker
KSKyle A. Smith
Kyle A. Smith
PMPreetesh L. Mylabathula
Preetesh L. Mylabathula
TZTiffany M. Zúñiga
Tiffany M. Zúñiga
DDDouglass M. Diak
Douglass M. Diak
EKEmmanuel Katsanis
Emmanuel Katsanis
Exercise mobilizes cytotoxic lymphocytes to blood which may allow superior cell products to be harvested and manufactured for cancer therapy. Gamma-Delta (γδ) T-cells have shown promise for treating solid tumors, but there is a need to increase their potency against hematologic malignancies. Here, we show that human γδ T-cells mobilized to blood in response to just 20 minutes of graded exercise have surface phenotypes and transcriptomic profiles associated with cytotoxicity, adhesion, migration, and cytokine signaling. Following 14 days ex vivo expansion with zoledronic acid and IL2, exercise mobilized γδ T-cells had surface phenotypes and transcriptomic profiles associated with enhanced effector functions and demonstrated superior cytotoxic activity against multiple hematologic tumors in vitro and in vivo in leukemia-bearing xenogeneic mice. Infusing humans with the β1+β2-agonist isoproterenol and administering β1 or β1+β2 antagonists prior to exercise revealed these effects to be β2-adrenergic receptor (AR) dependent. Antibody blocking of DNAM-1 on expanded γδ T-cells, as well as the DNAM-1 ligands PVR and Nectin-2 on leukemic targets, abolished the enhanced antileukemic effects of exercise. These findings provide a mechanistic link between exercise, β2-AR activation, and the manufacture of superior γδ T-cell products for adoptive cell therapy against hematologic malignancies. Significance: Exercise mobilizes effector γδ T-cells to blood via β2-adrenergic signaling which allows for generation of a potent expanded γδ T-cell product that is highly cytotoxic against hematologic malignancies.

11 September 2018 in Obesity
Verified
Journal Article
Closed access
PDF file
GNGrace Niemiro
Grace Niemiro
SSSarah K. Skinner
Sarah K. Skinner
AWAnne M. Walk
Anne M. Walk
CECaitlyn G. Edwards
Caitlyn G. Edwards
MLMichael De Lisio
Michael De Lisio
Naiman KhanNaiman Khan
Naiman Khan

17 February 2025 in Children
Verified
Journal Article
Open access
PDF file
JLJohn Lasekan
John Lasekan
QYQi Yao
Qi Yao
YCYong Choe
Yong Choe
GNGrace Niemiro
Grace Niemiro
PHPenni Hicks
Penni Hicks
Background/Objective: Inadequate nutrient intake in childhood can have lasting detrimental developmental and health outcomes. The objective of this study was to identify key nutrient intake gaps among US children. Method: Using the National Health and Nutrition Examination Survey 2015–2016 data, we compared nutrient intakes against dietary reference intakes (DRIs). Participants were grouped by age (in years): 0–0.5, 0.6–1, 1–4, 5–8, 9–14, and 15–19. Gender differences were assessed in the two older groups. Results: Linoleic acid, linolenic acid, vitamin D, and choline were the most consumed at lesser than DRIs in all age groups. Additionally, dietary fiber, vitamin A, vitamin E, vitamin K, folate, iron, and calcium were consumed at lesser than DRIs in 1–19 year olds. They also had an inadequate intake of docosahexaenoic acid (DHA). Children with nutrient intake gaps increased from infancy and toddlerhood to school-age period, with the inflection point at 5–8 years of age when parents have limited control on children’s nutrient intake. Above 9 years of age, females had greater nutrient intake gaps than males. Females in the 15–19-year-old segment especially had higher nutrient intake gaps (p < 0.05) for vitamin D, thiamin, riboflavin, vitamin B12, folate, iron, calcium, magnesium, phosphorus, and potassium compared to males. Selected laboratory biomarkers were used to verify the nutrient intake data. Conclusions: Key nutrient intake gaps were identified among different age groups of children in the US, which may have implications for future dietary interventions and target food formulations to help narrow these gaps.

13 May 2024
Verified
Other
Open access
Forrest BakerForrest Baker
Forrest Baker
KSKyle A. Smith
Kyle A. Smith
PMPreetesh L. Mylabathula
Preetesh L. Mylabathula
TZTiffany M. Zúñiga
Tiffany M. Zúñiga
DDDouglass M. Diak
Douglass M. Diak
EKEmmanuel Katsanis
Emmanuel Katsanis
ISO infusion enhances the antileukemic activity of ex vivo expanded Vγ9Vδ2+ T-cells in vitro and in vivo. A, Schematic of the experimental design for in vitro and in vivo experiments. B, The total number (1 × 106) of Vγ9Vδ2+ cells isolated before (REST) and during the final 5 minutes of ISO infusion at day 0, and the total number of Vγ9Vδ2+ T-cells generated in the expanded cell products after stimulation with ZOL+IL2 for 14 days. The number of Vγ9Vδ2+ cells generated at day 14 relative to the number of γδ cells in the PBMC fractions at day 0. The cellular composition of the expanded Vγ9Vδ2+ T-cell products at day 14. The proportions of naïve (N), CM, EM, and CD45RA+ EMRA cells among Vγ9Vδ2+ T-cells after 14 days of expansion (n = 7). C, The in vitro anti-tumor activity of ex vivo expanded Vγ9Vδ2+ T-cells against K562, Daudi, and U266 cells via flow cytometry–based assays. Significance indicated by ** (P < 0.01) and *** (P < 0.001). D, To determine the in vivo GvL effect of ISO expanded Vγ9Vδ2+, NSG-IL15 mice were injected with REST or ISO expanded Vγ9Vδ2+ (10 × 106) and challenged with 1 × 106 luciferase tagged human chronic myeloid leukemia cells (K562-luc). A subset of mice in each group were also provided weekly injections of ZOL (REST+ZOL; ISO+ZOL; VEHICLE +ZOL). The BLI (photons/second) scores, TFS, change in BW, and probability of survival after injection of expanded Vγ9Vδ2+ T-cells with or without ZOL sensitization (n = 7–8/group). BLI significant difference from EX+ZOL and EX conditions indicated by * and #, respectively (all conditions were significantly different from vehicle controls). TFS, BW, and OS significant difference from vehicle controls were indicated by * (TFS; EX, EX+ZOL, and REST+ZOL significance indicated by a single marker). E, Representative bioluminescence images of leukemia-bearing mice that received (from left to right) vehicle, vehicle + ZOL, REST expanded Vγ9Vδ2+ T-cells, REST expanded Vγ9Vδ2+ T-cells + ZOL, ISO expanded Vγ9Vδ2+ T-cells, and ISO expanded Vγ9Vδ2+ T-cells + ZOL. BLI intensity on a scale from low (purple) to high (red). Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by Students two-tailed paired t test (B); Repeated measures two-way ANOVA or LMM with Bonferroni post hoc test (C–D); log-rank (Mantel–Cox) test (D).

13 May 2024
Verified
Other
Open access
Forrest BakerForrest Baker
Forrest Baker
KSKyle A. Smith
Kyle A. Smith
PMPreetesh L. Mylabathula
Preetesh L. Mylabathula
TZTiffany M. Zúñiga
Tiffany M. Zúñiga
DDDouglass M. Diak
Douglass M. Diak
EKEmmanuel Katsanis
Emmanuel Katsanis
Interactions between DNAM-1 and PVR/Nectin-2 enhances the antileukemic activity of exercise expanded Vγ9Vδ2+ T-cells. A, Illustration of the receptors expressed on Vγ9Vδ2+ T-cells and their corresponding ligands expressed on cancer cells. B, Heat map of the surface expression and MFI of ligands and receptors on K562 cells. C and D, The specific lysis of K562 cells by expanded Vγ9Vδ2+ T-cells under two conditions: unstained control (−) and respective blocking antibody (+), DNAM-1, PVR, Nectin-2, TRAIL, TRAIL-R1, and TRAIL-R2 (n = 3). Significant differences between the between the unstained (−) and blocking conditions (+) were indicated by * and #, respectively. Data are represented as mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001 by repeated measures two-way ANOVA with Bonferroni post hoc test (C–D).